Leveraging Evolutionary Immunology in Interleukin-6 and Interleukin-17 Signaling for Lung Cancer...

Date : 25 Nov 2024

Khilwani R, Singh S.*  Leveraging Evolutionary Immunology in Interleukin-6 and Interleukin-17 Signaling for Lung Cancer Therapeutics. ACS Pharmacology & Translational Science. November 22. 2024.  https://doi.org/10.1021/acsptsci.4c00412.

Link : https://pubs.acs.org/doi/10.1021/acsptsci.4c00412